Dr.  

Bruce Strober

, United States


Chair

IPC - International Psoriasis Council
Subspecialty / International Society Meeting
09 October 2019 09:00 - 13:00 More ...

Presentations

Dupilumab improves outcomes in patients with atopic dermatitis (AD) in clinical practice - results from the RELIEVE-AD study 09 October 2019 00:00 - 00:00 More ...
Long-term Efficacy and Safety of Switching from Ustekinumab to Risankizumab: Results from the Open-Label Extension LIMMitless 09 October 2019 00:00 - 00:00 More ...
Reasons for drug discontinuation among patients in the Corrona Psoriasis Registry 09 October 2019 00:00 - 00:00 More ...
Classifying disease severity 09 October 2019 11:30 - 12:00 More ...

Abstracts

Dupilumab improves outcomes in patients with atopic dermatitis (AD) in clinical practice - results from the RELIEVE-AD study Atopic Dermatitis/Eczema More
Reasons for drug discontinuation among patients in the Corrona Psoriasis Registry Psoriasis More